Tracked deals
12
12 tracked deals across 2020-2026.
Pharmaceuticals Buyers & Acquisitions in Pennsylvania
Buyer mix
Mixed buyer set
9 strategic · 8 pe
Top trend
Volume peaked in 2020
4 tracked deals announced in 2020.
Buyer Snapshot
Top Buyers
Illustrative buyers pulled from tracked transactions on this page. This table is capped and intentionally non-exhaustive.
| Buyer | # Deals | Focus | Type |
|---|---|---|---|
| Frazier Healthcare Partners | 2 | Healthcare‑focused middle‑market private equity firm inve... | PE |
| Thomas H. Lee Partners | 2 | Middle‑market private equity firm investing across Consum... | PE |
| Adare Pharma Solutions | 1 | Technology-driven contract development and manufacturing ... | Strategic (PE-backed) |
| Altaris Capital Partners, LLC | 1 | Private equity firm focused on healthcare investments and... | PE |
| Altasciences | 1 | Mid-size integrated contract research organization (CRO) ... | Strategic |
| B-FLEXION Life Sciences | 1 | Investment manager within the B-FLEXION group that seeds,... | PE |
| Blackstone Credit & Insurance | 1 | Private credit and insurance investment platform providin... | Mixed |
| BroadOak Capital Partners | 1 | Life-sciences–focused private investment firm providing d... | PE |
| Charterhouse Capital Partners LLP | 1 | European private equity firm focused on mid‑market invest... | PE |
| Consegna Pharma Inc. | 1 | Drug delivery company leveraging computational technologi... | Strategic |
Acquisition Volume in Pharmaceuticals in Pennsylvania by Year
Last 6 years
Actual
Full-year estimate
Supporting Data
Recent Transactions
-
- Buyer
- Paratek Pharmaceuticals, Inc., B-FLEXION Life Sciences, Blackstone Credit & Insurance, Sixth Street, Oaktree Capital Management, L.P., Silver Point Capital, Pharmakon Advisors, LP
- Target
- Radius Health, Inc.
- Industry
- Pharmaceuticals
- Location
- Pennsylvania, United States
- Type
- Buyout
Paratek Pharmaceuticals completed its combination with Radius Health, adding Radius’s osteoporosis therapy TYMLOS (abaloparatide) to Paratek’s specialty pharmaceutical portfolio. The combined company is expected to generate nearly $1 billion in revenue in 2026 and expands the platform across multiple high-need therapeutic areas.
-
- Buyer
- Cooper Consumer Health
- Target
- Viatris Inc. Over-the-Counter (OTC) business
- Seller
- Viatris Inc.
- Industry
- Pharmaceuticals
- Location
- Pennsylvania, United States
- Type
- Divestiture
Cooper Consumer Health has completed the acquisition of the Over-the-Counter (OTC) business of Viatris Inc., following regulatory approvals and worker council consultations. The deal brings more than 200 brands (including Betadine, Saugella, Armolipid and CB12), two manufacturing sites in Mérignac (France) and Confienza (Italy) and an R&D centre in Monza (Italy) into Cooper's platform, doubling Cooper's revenues to approximately €1.2bn.
-
August 14, 2023
- Buyer
- Harmony Biosciences Holdings, Inc.
- Target
- Zynerba Pharmaceuticals, Inc.
- Industry
- Pharmaceuticals
- Location
- Pennsylvania, United States
- Type
- Buyout
Harmony Biosciences Holdings, Inc. has signed a definitive agreement to acquire Zynerba Pharmaceuticals, Inc. in a cash tender offer valued at $60 million at closing ($1.1059 per share) plus a non-tradeable contingent value right (CVR) with potential additional payments of up to $140 million, for total potential consideration of up to $200 million. The deal is expected to close in the fourth quarter of 2023, subject to customary closing conditions and tendering by at least a majority of Zynerba’s outstanding shares.
-
- Buyer
- BroadOak Capital Partners, Investor group of industry veterans (including Derek Hennecke and TJ Higley)
- Target
- Microsize
- Seller
- Lonza
- Industry
- Pharmaceuticals
- Location
- Pennsylvania, United States
- Type
- Divestiture
BroadOak Capital Partners led an investor-backed launch of Microsize after acquiring Lonza’s North American micronization business in Quakertown, Pennsylvania. The newly independent CDMO — operating three facilities and focused on micronization and particle-size control for APIs and excipients — will be run by industry veterans including Chairman Derek Hennecke and CEO TJ Higley to expand US-based API solubility and bioavailability enhancement capabilities.
-
- Buyer
- Altaris Capital Partners, LLC
- Target
- Veranova (formerly Johnson Matthey's Health business)
- Seller
- Johnson Matthey PLC
- Industry
- Pharmaceuticals
- Location
- Pennsylvania, United States
- Type
- Buyout
Altaris Capital Partners completed the acquisition of Veranova (formerly Johnson Matthey's Health business) from Johnson Matthey PLC for total consideration of up to £325 million, with Johnson Matthey retaining approximately a 30% equity stake. Veranova is a global CDMO focused on specialty and complex active pharmaceutical ingredients (APIs), headquartered in Wayne, Pennsylvania, with roughly 900 employees across seven development and manufacturing sites in North America, Europe and Asia.
-
April 19, 2022
- Buyer
- Consegna Pharma Inc.
- Target
- Fathom Pharma LLC
- Industry
- Pharmaceuticals
- Location
- Pennsylvania, United States
- Type
- Buyout
Consegna Pharma Inc. has acquired Fathom Pharma LLC, making Fathom a wholly owned subsidiary to strengthen Consegna's long-acting injectable (LAI) portfolio and initiatives addressing the opioid crisis. The acquisition is intended to accelerate clinical development of long-acting pain therapeutics that are designed to be less susceptible to abuse or diversion.
-
December 1, 2021
- Buyer
- Adare Pharma Solutions, Thomas H. Lee Partners, Frazier Healthcare Partners
- Target
- Frontida BioPharm
- Industry
- Pharmaceuticals
- Location
- Pennsylvania, United States
- Type
- Addon
Adare Pharma Solutions, a PE-backed contract development and manufacturing organization (CDMO), has acquired Frontida BioPharm, a vertically integrated CDMO focused on oral formulations. The deal expands Adare’s capabilities—including high-potency compound handling and packaging services—and increases its manufacturing footprint; Adare is backed by Thomas H. Lee Partners and Frazier Healthcare Partners.
-
February 5, 2021
- Buyer
- PMC Group International, Inc.
- Target
- Cobra Investments Management Inc., Copperhead Chemical Company Inc., Copperhead Investments Inc.
- Seller
- Group of previous owners (unnamed)
- Industry
- Pharmaceuticals
- Location
- Pennsylvania, United States
- Type
- Buyout
PMC Group International, Inc. announced the acquisition of Cobra Investments Management Inc. and its two subsidiaries, Copperhead Chemical Company Inc. and Copperhead Investments Inc., effective February 5, 2021. Copperhead, headquartered in Tamaqua, Pennsylvania, is a long-established manufacturer of pharmaceutical-grade nitroglycerin and energetic chemicals for defense; PMC said the deal strengthens its pharmaceutical manufacturing capabilities and creates synergies with its global pharma and specialty-chemicals businesses.
-
December 1, 2020
- Buyer
- Laboratoires SERB, Charterhouse Capital Partners LLP
- Target
- BTG Specialty Pharmaceuticals
- Seller
- Boston Scientific
- Industry
- Pharmaceuticals
- Location
- Pennsylvania, United States
- Type
- Addon
Charterhouse Capital Partners–backed Laboratoires SERB has agreed to acquire BTG Specialty Pharmaceuticals from Boston Scientific. The deal expands SERB’s portfolio of emergency and critical‑care medicines (including CroFab, DigiFab and Voraxaze), strengthening its manufacturing capabilities and global commercial reach.
-
September 22, 2020
- Buyer
- Thomas H. Lee Partners, Frazier Healthcare Partners
- Target
- Adare Pharmaceuticals (Adare Pharma Solutions)
- Seller
- TPG Capital
- Industry
- Pharmaceuticals
- Location
- Pennsylvania, United States
- Type
- Buyout
Thomas H. Lee Partners and Frazier Healthcare Partners have acquired Adare Pharmaceuticals (to be rebranded Adare Pharma Solutions) from TPG Capital. The deal includes Adare’s CDMO, pharmaceutical technology and microbiome businesses while TPG retained rights to an EoE product spun into a separate entity; terms were not disclosed.
-
August 25, 2020
- Buyer
- Pace Analytical Services, LLC
- Target
- Emerson Resources, Inc.
- Seller
- Emerson Resources principals / owners (Jay Signorino and Chip Signorino)
- Industry
- Pharmaceuticals
- Location
- Pennsylvania, United States
- Type
- Buyout
Pace Analytical Services, LLC acquired Emerson Resources, Inc., a CDMO specializing in solid oral dosage development and cGMP clinical trial material manufacturing. The acquisition expands Pace Life Sciences' capabilities to include clinical trial material production and transitions Emerson's Norristown, Pennsylvania lab into the Pace Analytical network while Emerson principals exit the business.
-
February 27, 2020
- Buyer
- Altasciences
- Target
- Alliance Contract Pharma
- Industry
- Pharmaceuticals
- Location
- Pennsylvania, United States
- Type
- Buyout
Altasciences, a mid-size contract research organization based in Laval, Quebec, has acquired Alliance Contract Pharma to add small-molecule contract manufacturing and analytical services, including commercial manufacturing, GMP warehouse storage, and clinical supply distribution. The acquisition expands Altasciences' integrated early‑phase drug development offering by adding manufacturing and analytical capabilities to its preclinical, clinical, and bioanalytical services.
Build a buyer list for your Pharmaceuticals deal
Find buyers actively acquiring pharmaceuticals companies.
Related Acquisition Pages
Pharmaceuticals Buyers & Acquisitions
Pharmaceuticals Buyers & Acquisitions in Canada
Private Equity-Backed Pharmaceuticals Buyers
Pharmaceuticals Acquisitions in 2026
Pharmaceuticals Acquisitions in 2024
Pharmaceuticals Acquisitions in 2023
Pharmaceuticals Acquisitions in 2022
Pharmaceuticals Acquisitions in 2021
Pharmaceuticals Acquisitions in 2020
Acquisitions in Pennsylvania
Private Equity-Backed Acquisitions in Pennsylvania
Acquisitions in Pennsylvania in 2026